Abstract | OBJECTIVE: DESIGN: Multicentric, single-blind, controlled, randomised intervention study. SETTING: Primary Health Care Centers in Lezo, Beraun, Andoain and Irún (Gipuzkoa, Spain). PATIENTS: Infants less than 12 months old (n = 94) diagnosed with mild bronchiolitis. INTERVENTION: We established two groups of patients: group 1 (n = 47) was treated with inhaled beclomethasone (250 pg/12 hours) using a valved holding chamber (Babyhaler); the treatment started eight days after diagnosis of bronchiolitis and lasted 3 months. Group 2 (n = 47) received no treatment. We compared the number of wheezing episodes and their severity during the intervention period (3 months) and the follow-up period (12 months) with the Students t-test and the Chi-squared test. RESULTS: We studied 89 infants (group 1, n = 42; group 2, n = 47), 67% of whom wheezed during the study period (15 months). There were no significant differences between the treatment and the control group in the study periods. CONCLUSIONS: Inhaled beclomethasone given for 3 months does not significantly modify the occurrence of wheezing episodes during the treatment period or during the following 12 months.
|
Authors | M Callén Blecua, P Aizpurua Galdeano, I Ozcoidi Erro, L Mancisidor Aguinagalde, C Guedea Adiego, E Busselo Ortega, I Ibarrondo Uriarte |
Journal | Anales espanoles de pediatria
(An Esp Pediatr)
Vol. 52
Issue 4
Pg. 351-5
(Apr 2000)
ISSN: 0302-4342 [Print] Spain |
Vernacular Title | Glucocorticoides inhalados y sibilancias posbronquiolitis. |
PMID | 11203411
(Publication Type: Clinical Trial, English Abstract, Journal Article, Multicenter Study, Randomized Controlled Trial)
|
Chemical References |
- Glucocorticoids
- Beclomethasone
|
Topics |
- Administration, Inhalation
- Beclomethasone
(administration & dosage)
- Bronchiolitis
(drug therapy)
- Female
- Glucocorticoids
(administration & dosage)
- Humans
- Infant
- Male
- Respiratory Sounds
(drug effects)
- Single-Blind Method
|